Offers a comprehensive overview of matrix organizations within the pharmaceutical industry, explaining their structure, benefits, and inherent challenges. It details how these organizations, characterized by dual or multiple reporting lines, foster innovation and agility by enabling cross-functional teams and horizontal information flow. However, the text also highlights significant dysfunctions, such as role ambiguity and unclear decision rights, which can lead to project delays and reduced efficiency. To address these issues, the source emphasizes the importance of tools like RASCI/RACI charts and Decision Rights Frameworks, and it outlines strategies for leaders to build influence without formal authority in these complex, interconnected environments.